Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It most commonly affects the lungs, but can also impact other organs. It is transmitted through airborne droplets, such as those produced by coughing, sneezing, or speaking by an infected person. Tuberculosis is one of the deadliest infectious diseases, with approximately 10 million people falling ill each year. This disease is particularly prevalent in countries with low and middle economic status and where healthcare systems are weak, such as in Africa and Southeast Asia. Each disease has its risk factors, and patients with HIV infection or immunocompromised individuals are at high risk for developing tuberculosis. Symptoms include persistent cough, chest pain, weight loss, night sweats, and fatigue. Microbiological samples are the "gold standard" for detecting tuberculosis. The most common sample taken is the patient's sputum, along with medical history data, radiological methods, and the Mantoux test. Tuberculosis is a curable disease; however, it requires significant effort. It is treated with a combination of first-line anti-tuberculosis drugs, and if the bacterium becomes resistant, second-line anti-tuberculosis drugs are used. Treatment is long and expensive. This thesis aimed to present the differences between genders, age groups, the symptoms with which individuals present, and the methods and duration of treatment. Three hypotheses were proposed, two of which were accepted. The research showed that the incidence of pulmonary tuberculosis has been decreasing in the past year and that the affected individuals are of older age. Since tuberculosis remains a public health issue, medical staff play a crucial role, starting with prevention and continuing with the treatment of tuberculosis. Emphasis is placed on the multidisciplinary team, whose cooperation is essential for the successful recovery of the patient.